Federal officials told lawmakers Tuesday that the 340B drug discount program needs greater transparency and more clarity about which providers and patients should be eligible.
Universal Hospital Services reported another 12 months of disappointing financial results with the healthcare technology and medical-device supplier recording a net loss of $66.5 million for the year ended Dec. 31, 2014.
The average cost of angiography systems dropped 25% in January compared with the same month last year, as buyers showed less interest in purchasing higher-end systems, according to the Modern Healthcare/ECRI Institute Technology Price Index.
MedAssets has added two new officers to its C-suite, just over a month after its founder, John Bardis, stepped down as CEO.
New cost-effectiveness analyses of Sovaldi and other treatments to treat chronic hepatitis C infection suggest U.S. firms initially set prices near the ceiling that the United Kingdom's National Health Service will pay for drugs.
New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market.
Recent inspections at several Chicago hospital kitchens revealed major issues with pests and food temperature control even as some patient-serving kitchens went years without being inspected.
The U.S. Food and Drug Administration announced Wednesday the launch of a mobile app for health professionals to get quick information on drug shortages.
The median prices for selected costly hospital products dipped in 2014 as hospital supply-chain leaders continued to negotiate tougher deals and clamp down on physician-preference items.
Providers are considering investing in lung programs that focus on early diagnosis as well as care coordination that smoothly guides a patient from diagnosis to treatment and recovery.
UCSF Medical Center opened its new Mission Bay Campus to patients in early February, welcoming new employees—some of whom are robots.
John Bardis, chairman and CEO of MedAssets, has resigned from the company, effectively immediately, for “personal reasons” related to family health issues, MedAssets said Tuesday.